Amniotic tissue transplantation: clinical and biochemical evaluations for some lysosomal storage diseases.
Amniotic epithelial cells has been used for transplantation in patients with lysosomal storage diseases as an enzyme replacement therapy. But its clinical effect is still the question under debate. We performed amniotic tissue transplantation on patients with different lysosomal storage diseases: one with Tay-Sachs disease, one with juvenile Gaucher disease and one with juvenile metachromatic leukodystrophy. The patient having juvenile Gaucher disease received this grafting twice. Objective clinical improvement was observed in the first trial where this patient showed an increase of soluble beta-glucosidase one week after implantation. No clinical or biochemical changes were seen in the other patients. Although there are some advantages to amniotic tissue transplantation, original methods should be modified to cell transplantation in order to avoid graft-versus-host reaction which could happen in repeated implantation.
Sakuragawa
N
N
Division of Inherited Metabolic Diseases, National Institute of Neuroscience, NCNP, Tokyo.
Yoshikawa
H
H
Sasaki
M
M
D000293:Adolescent; D000650:Amnion / Q000166:cytology / Q000637:transplantation*; D002675:Child, Preschool; D005321:Extraembryonic Membranes / Q000166:cytology; D005260:Female; D016332:Fetal Tissue Transplantation / Q000502:physiology*; D005776:Gaucher Disease / Q000628:therapy; D005966:Glucuronidase / Q000097:blood; D006801:Humans; D007966:Leukodystrophy, Metachromatic / Q000628:therapy; D016464:Lysosomal Storage Diseases / Q000378:metabolism / Q000628:therapy*; D008297:Male; D013661:Tay-Sachs Disease / Q000628:therapy
D005966:Glucuronidase